Expanded Access Program With Nivolumab to Treat Melanoma
Public ClinicalTrials.gov record NCT02142218. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Expanded Access Program With Nivolumab for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Systemic Treatment Containing an Anti CTLA-4 Monoclonal Antibody (Checkmate 168: CHECKpoint Pathway for nivoluMAb Clinical Trial Evaluation 168)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this program is to provide treatment with nivolumab to subjects with Stage III or Stage IV advanced melanoma.
Study identification
- NCT ID
- NCT02142218
- Recruitment status
- No Longer Available
- Study type
- Expanded access
- Phase
- Not listed
- Enrollment
- Not listed
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2014 (Type not available)
- Primary completion
- May 2018 (Estimated)
- Completion
- May 2018 (Estimated)
- Last update posted
- Sep 29, 2016
2014 – 2018
United States locations
- U.S. sites
- 23
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Mobile | Alabama | 36604 | — |
| Southern Cancer Center Pc | Mobile | Alabama | 36608 | — |
| Local Institution | Encinitas | California | 92024 | — |
| Local Institution | Washington D.C. | District of Columbia | 20057 | — |
| Lynn Cancer Institute At Boca Raton Regional Hospital | Boca Raton | Florida | 33486 | — |
| Cancer Specialists Of North Florida | Jacksonville | Florida | 32256 | — |
| Mount Sinai Comprehensive Cancer Center | Miami Beach | Florida | 33140 | — |
| Florida Hospital | Orlando | Florida | 32803 | — |
| Winship Cancer Institute | Atlanta | Georgia | 30322 | — |
| Summit Cancer Care | Savannah | Georgia | 31404 | — |
| Oncology Specialists, S.C. | Park Ridge | Illinois | 60068 | — |
| Oncology Hematology Associates Of Sw In | Newburgh | Indiana | 47630 | — |
| Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins | Lutherville | Maryland | 21093 | — |
| Nebraska Cancer Specialists | Omaha | Nebraska | 68130 | — |
| Comprehensive Cancer Centers Of Nevada | Las Vegas | Nevada | 89148 | — |
| North Shore Hematology/Oncology Associates, P.C. | East Setauket | New York | 11733 | — |
| Icahn School Of Medicine At Mount Sinai | New York | New York | 10029 | — |
| Mid Ohio Oncology/Hematology, Inc,Dba | Columbus | Ohio | 43219 | — |
| Lehigh Valley Health Network | Allentown | Pennsylvania | 18103 | — |
| St. Luke'S Hospital | Bethlehem | Pennsylvania | 18015 | — |
| The Jones Clinic, Pc | Germantown | Tennessee | 38138 | — |
| Tennessee Oncology, PLLC | Nashville | Tennessee | 37203 | — |
| Waukesha Memorial Hospital | Waukesha | Wisconsin | 53188 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02142218, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 29, 2016 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02142218 live on ClinicalTrials.gov.